Developer docs
API playgroundTry for free, no card

Search company profiles

NXT-USA

Full company profile

uuid002mcox

Namestring
NXT-USA
Legal namestring
NXT-USA
Websiteurl
nxt-usa.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

NXT-USA is a privately held B2B nutraceutical ingredient supplier headquartered in Edison, New Jersey, founded by the team that previously co-founded NattoPharma ASA and introduced vitamin K2 Mk-7 to global markets. The company supplies proprietary, clinically validated botanical ingredients to nutritional supplement manufacturers, finished product brands, and regional distributors. Its portfolio consists of four branded ingredients: TamaFlex (joint health via Tamarind seed and Turmeric root with a patented Triple OX Pathway mechanism), Xeya Modern Shatavari (women's hormonal health, standardized to 15% shatavarins), Digexin (digestive health via a gut-brain axis approach using Okra and Ashwagandha), and BluNADBooster (plant-based NAD+ longevity). Each ingredient is backed by double-blind, placebo-controlled human clinical trials published in peer-reviewed journals, with TamaFlex currently registered and Digexin and BluNADBooster patent-pending.

NXT-USA operates an asset-light model: it owns formulation IP, trademarked brands, and clinical evidence, while manufacturing is outsourced to partners in the United States, Scandinavia, Europe, and India, with sourcing compliant with India's Biological Diversity Act. Revenue is generated through B2B ingredient sales (quote-based, not publicly disclosed) and licensing arrangements with branded customers that include Tylenol (Kenvue), Schiff (Reckitt), GNC, Solgar, MegaFood, Life Extension, Qualia, Gundry MD, and Instaflex. Geographic distribution is supported by channel partners including Shanghai Nutra (China/Asia, 2022) and Infinity Pharma Brazil (Brazil, 2024). The company holds regulatory certifications including Non-GMO Project Verification, Korean MFDS functional food approval for TamaFlex, and cGMP manufacturing compliance.

The company is led by Managing Director Eric Anderson, with Todd Runestad joining as Chief Storytelling Officer in March 2025. Headcount is reported at 1-10 employees and no institutional funding rounds are disclosed, indicating founder-led, bootstrapped operations. Recent strategic emphasis has been on portfolio diversification (two new ingredient launches in 2025), regulatory expansion in Asian markets, and brand storytelling investment, suggesting a transition from a single-ingredient (TamaFlex) supplier to a multi-ingredient, multi-region specialty ingredient platform.

Short descriptiontext

NXT-USA is a privately held B2B nutraceutical ingredient supplier selling four clinically validated proprietary botanical ingredients (TamaFlex, Digexin, Xeya, BluNADBooster) to supplement manufacturers and brands in joint, digestive, women's health, and longevity categories globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEdison, United States
HQ citystring
Edison
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nutraceutical ingredient supplier, proprietary botanical extracts, joint health ingredients, digestive health ingredients, women's hormonal health ingredients
Industry1 code
PRIMARYAFAJAKAD
Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Nutraceutical Ingredients
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1B2B Ingredient Sales
TypeLicensing Royalties
Description

NXT-USA supplies proprietary branded ingredients to nutritional supplement manufacturers and finished product brands. Revenue is generated through ingredient sales, licensing, and partnerships with brands incorporating their clinically validated botanical extracts into their products.

nxt-usa.com
2B2B Sales Model
TypeOne Time License
Description

Direct B2B sales to qualified industry professionals, manufacturers, and resellers in the United States and globally through distribution partners.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1TamaFlex
Description

Patented plant-based joint health ingredient combining Tamarind Seed and Turmeric Root Extracts, clinically proven to provide fast-acting and long-lasting joint relief.

nxt-usa.com
+3 more records
Core offering1 text field

NXT-USA supplies four proprietary, clinically validated botanical branded ingredients — TamaFlex (joint health), Xeya Modern Shatavari (women's hormonal health), Digexin (digestive health and gut-brain axis), and BluNADBooster (NAD+ longevity) — to nutritional supplement manufacturers and finished product brands globally. Revenue is generated by selling these patented or patent-pending ingredient formulations, backed by human clinical studies, under licensing and direct supply agreements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • TamaFlex shows significant joint pain improvement in 5 days and improved physical function in 90-day studies with 89-150+ participants
+3 more records
Product overview1 text field

NXT-USA is a B2B nutraceutical ingredient company providing clinically validated health ingredients to manufacturers. The product portfolio consists of four branded ingredients: TamaFlex (joint health using Tamarind and Turmeric via Triple OX Pathway mechanism), Xeya Modern Shatavari (women's hormonal health for PCOS, perimenopause and menopause support), Digexin (digestive/gut health via gut-brain axis using Okra and Ashwagandha), and BluNADBooster (cellular longevity via NAD+ biosynthesis activation and CD38 inhibition). All products are backed by human clinical trials published in peer-reviewed journals, with emphasis on double-blind, placebo-controlled studies.

Product and service4 records
1TamaFlex
CategoryJoint Health Ingredient
Description

Patented plant-based joint health ingredient combining Tamarind Seed and Turmeric Root extracts, clinically proven to provide fast-acting (5-day) and long-lasting joint relief through the Triple OX Pathway (COX, LOX, AntiOX). Sold to nutritional supplement manufacturers and brands for use in finished consumer joint-health products.

2Xeya Modern Shatavari
CategoryWomen's Hormonal Health Ingredient
Description

Trademarked Ayurvedic adaptogen for women's hormonal health, standardized to 15% shatavarins and clinically validated for hormonal balance across PCOS, perimenopause, and menopause. Effective at a low 50–100 mg/day dose and available in water-dispersible format. Sold B2B to supplement brands formulating women's health products.

3Digexin
CategoryDigestive Health Ingredient
Description

Patent-pending proprietary herbal extract combining tender okra pods and winter cherry (Ashwagandha) root to support digestive regularity and gut-brain axis communication through four mechanisms: epithelial lubrication, increased peristalsis, prebiotic effect, and adaptogenic cortisol/serotonin modulation. Sold to supplement brands for digestive health formulations; results clinically shown in 7 days.

4BluNADBooster
CategoryLongevity and NAD+ Support Ingredient
Description

Patent-pending, clinically studied plant-based NAD+ longevity ingredient combining pomegranate and marigold flower extracts to dual-pathway activate NAD+ biosynthesis (Salvage and Preiss-Handler pathways) and inhibit the CD38 enzyme. Marketed as a natural alternative to synthetic NAD+ precursors such as NR and NMN, for use in healthy aging and longevity supplement formulations.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Twin Arbor Labs
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-01
Description

NXT-USA partnered with Twin Arbor Labs to establish the first independent testing method for Xeya Modern Shatavari extract. This partnership allows clients to independently confirm that every batch meets the same standards used in clinical research.

nxt-usa.com
2Infinity Pharma Brazil
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-07-30
Description

NXT-USA announced partnership with Infinity Pharma Brazil to launch Digexin in Brazil under the brand name Motility. This partnership expands global footprint and brings digestive wellness products to the Brazilian market.

nxt-usa.com
3Shanghai Nutra (Shanghai Freemen)
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-10-04
Description

NXT-USA partnered with Shanghai Nutra to launch Digexin as a new digestive health ingredient at SupplySide West in October 2022. Shanghai Nutra serves as a distribution and co-marketing partner for the Chinese and Asian markets.

nxt-usa.com
4Laila Nutra Private Limited
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Xeya trademark is owned by Laila Nutra Private Limited. NXT-USA has an exclusive or licensed relationship for the Xeya Modern Shatavari ingredient in global markets. Laila Nutra developed the proprietary extraction and standardization process delivering 15% shatavarins.

nxt-usa.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Sabinsa
TypeDirect peer
Description

Specializes in branded, patented, clinically validated botanical ingredients (e.g., curcumin C3 Complex, Boswellin) sold B2B to supplement manufacturers worldwide — directly comparable model to NXT-USA across turmeric/joint and women's health adjacencies.

2OmniActive Health Technologies
TypeDirect peer
Description

Supplies branded, science-backed nutraceutical ingredients (e.g., Lutemax, BioCurc) to brands globally — same B2B ingredient-supplier model, patent/trademark protected SKUs, and emphasis on peer-reviewed clinical evidence.

3Gencor
TypeDirect peer
Description

Global supplier of branded botanical extracts and ingredients (e.g., Libifem, Tesnor) targeting women's health, men's health, and general wellness — directly comparable ingredient portfolio and B2B go-to-market.

4PLT Health Solutions
TypeDirect peer
Description

B2B ingredient supplier focused on branded, clinically supported botanicals and naturals sold into supplement and functional food brands — comparable branded-ingredient distribution model.

5Nexira
TypeDirect peer
Description

Global supplier of natural botanical and nutritional ingredients with strong digestive-health and joint-health categories — directly comparable B2B ingredient model with overlap on gut-health adjacencies to Digexin.

6DolCas Biotech
TypeDirect peer
Description

Supplies branded, clinically researched botanical extracts (e.g., Curcugen, BosPure) to supplement manufacturers — same patented/standardized botanical B2B model with overlap on joint and inflammation categories.

7Verdure Sciences
TypeDirect peer
Description

Supplies branded, patented botanical extracts (e.g., Pomella, LongVida) to dietary supplement brands — comparable B2B ingredient model with emphasis on clinical substantiation and trademarked SKUs.

8Ingredients by Nature
TypeDirect peer
Description

Supplier of branded, research-backed botanical extracts (e.g., Curcumin C3, Prime Naturally) to supplement manufacturers — comparable B2B go-to-market and clinically validated positioning.

9Kuber Impex
TypeDirect peer
Description

India-based supplier of botanical and nutraceutical raw materials and proprietary extracts, including turmeric/curcumin derivatives — comparable upstream sourcing and B2B ingredient supplier model.

10Natural Remedies
TypeDirect peer
Description

India-headquartered manufacturer of clinically validated branded botanical extracts (e.g., BacoMind, Boswellia) supplied B2B to global supplement brands — directly comparable model on clinical validation, IP, and joint/women's health categories.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NXT-USA

Nutraceutical Ingredientsnxt-usa.com

NXT-USA is a privately held B2B nutraceutical ingredient supplier selling four clinically validated proprietary botanical ingredients (TamaFlex, Digexin, Xeya, BluNADBooster) to supplement manufacturers and brands in joint, digestive, women's health, and longevity categories globally.

What NXT-USA does

NXT-USA is a privately held B2B nutraceutical ingredient supplier headquartered in Edison, New Jersey, founded by the team that previously co-founded NattoPharma ASA and introduced vitamin K2 Mk-7 to global markets. The company supplies proprietary, clinically validated botanical ingredients to nutritional supplement manufacturers, finished product brands, and regional distributors. Its portfolio consists of four branded ingredients: TamaFlex (joint health via Tamarind seed and Turmeric root with a patented Triple OX Pathway mechanism), Xeya Modern Shatavari (women's hormonal health, standardized to 15% shatavarins), Digexin (digestive health via a gut-brain axis approach using Okra and Ashwagandha), and BluNADBooster (plant-based NAD+ longevity). Each ingredient is backed by double-blind, placebo-controlled human clinical trials published in peer-reviewed journals, with TamaFlex currently registered and Digexin and BluNADBooster patent-pending.

NXT-USA operates an asset-light model: it owns formulation IP, trademarked brands, and clinical evidence, while manufacturing is outsourced to partners in the United States, Scandinavia, Europe, and India, with sourcing compliant with India's Biological Diversity Act. Revenue is generated through B2B ingredient sales (quote-based, not publicly disclosed) and licensing arrangements with branded customers that include Tylenol (Kenvue), Schiff (Reckitt), GNC, Solgar, MegaFood, Life Extension, Qualia, Gundry MD, and Instaflex. Geographic distribution is supported by channel partners including Shanghai Nutra (China/Asia, 2022) and Infinity Pharma Brazil (Brazil, 2024). The company holds regulatory certifications including Non-GMO Project Verification, Korean MFDS functional food approval for TamaFlex, and cGMP manufacturing compliance.

The company is led by Managing Director Eric Anderson, with Todd Runestad joining as Chief Storytelling Officer in March 2025. Headcount is reported at 1-10 employees and no institutional funding rounds are disclosed, indicating founder-led, bootstrapped operations. Recent strategic emphasis has been on portfolio diversification (two new ingredient launches in 2025), regulatory expansion in Asian markets, and brand storytelling investment, suggesting a transition from a single-ingredient (TamaFlex) supplier to a multi-ingredient, multi-region specialty ingredient platform.

NXT-USA firmographics

Firmographics
Name
NXT-USA
Legal name
NXT-USA
Website
https://nxt-usa.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
NXT-USA is a privately held B2B nutraceutical ingredient supplier selling four clinically validated proprietary botanical ingredients (TamaFlex, Digexin, Xeya, BluNADBooster) to supplement manufacturers and brands in joint, digestive, women's health, and longevity categories globally.
Ownership category
akta.pro rank

NXT-USA industry classification

Industry
Product category
Nutraceutical Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYAFAJAKAD
Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)

Keywords

  • Nutraceutical ingredient supplier
  • Proprietary botanical extracts
  • Joint health ingredients
  • Digestive health ingredients
  • Women's hormonal health ingredients

Where NXT-USA is headquartered

Location

Headquarters

HQ city
Edison
HQ country
United States
HQ region
North America

Offices1 record

Markets served

NXT-USA business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. B2B Ingredient Sales: NXT-USA supplies proprietary branded ingredients to nutritional supplement manufacturers and finished product brands. Revenue is generated through ingredient sales, licensing, and partnerships with brands incorporating their clinically validated botanical extracts into their products.
  2. B2B Sales Model: Direct B2B sales to qualified industry professionals, manufacturers, and resellers in the United States and globally through distribution partners.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

NXT-USA product offering

Product offering

Core offering

NXT-USA supplies four proprietary, clinically validated botanical branded ingredients — TamaFlex (joint health), Xeya Modern Shatavari (women's hormonal health), Digexin (digestive health and gut-brain axis), and BluNADBooster (NAD+ longevity) — to nutritional supplement manufacturers and finished product brands globally. Revenue is generated by selling these patented or patent-pending ingredient formulations, backed by human clinical studies, under licensing and direct supply agreements.

Product overview

NXT-USA is a B2B nutraceutical ingredient company providing clinically validated health ingredients to manufacturers. The product portfolio consists of four branded ingredients: TamaFlex (joint health using Tamarind and Turmeric via Triple OX Pathway mechanism), Xeya Modern Shatavari (women's hormonal health for PCOS, perimenopause and menopause support), Digexin (digestive/gut health via gut-brain axis using Okra and Ashwagandha), and BluNADBooster (cellular longevity via NAD+ biosynthesis activation and CD38 inhibition). All products are backed by human clinical trials published in peer-reviewed journals, with emphasis on double-blind, placebo-controlled studies.

Differentiator

Problem solved

Functional benefit

Brands

  • TamaFlex: Patented plant-based joint health ingredient combining Tamarind Seed and Turmeric Root Extracts, clinically proven to provide fast-acting and long-lasting joint relief.
  • Xeya Modern Shatavari
  • Digexin
  • BluNADBooster

Products and services

  • TamaFlex Patented plant-based joint health ingredient combining Tamarind Seed and Turmeric Root extracts, clinically proven to provide fast-acting (5-day) and long-lasting joint relief through the Triple OX Pathway (COX, LOX, AntiOX). Sold to nutritional supplement manufacturers and brands for use in finished consumer joint-health products.
  • Xeya Modern Shatavari Trademarked Ayurvedic adaptogen for women's hormonal health, standardized to 15% shatavarins and clinically validated for hormonal balance across PCOS, perimenopause, and menopause. Effective at a low 50–100 mg/day dose and available in water-dispersible format. Sold B2B to supplement brands formulating women's health products.
  • Digexin Patent-pending proprietary herbal extract combining tender okra pods and winter cherry (Ashwagandha) root to support digestive regularity and gut-brain axis communication through four mechanisms: epithelial lubrication, increased peristalsis, prebiotic effect, and adaptogenic cortisol/serotonin modulation. Sold to supplement brands for digestive health formulations; results clinically shown in 7 days.
  • BluNADBooster Patent-pending, clinically studied plant-based NAD+ longevity ingredient combining pomegranate and marigold flower extracts to dual-pathway activate NAD+ biosynthesis (Salvage and Preiss-Handler pathways) and inhibit the CD38 enzyme. Marketed as a natural alternative to synthetic NAD+ precursors such as NR and NMN, for use in healthy aging and longevity supplement formulations.

Quantifiable outcome

  • TamaFlex shows significant joint pain improvement in 5 days and improved physical function in 90-day studies with 89-150+ participants
  • +3 more outcomes

Companies that use NXT-USA

Customer profile

Named customers13 records

Segments3 records

Ideal customer profiles2 records

NXT-USA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

NXT-USA partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Twin Arbor LabscoreTechnology or Integration · 1 April 2026NXT-USA partnered with Twin Arbor Labs to establish the first independent testing method for Xeya Modern Shatavari extract. This partnership allows clients to independently confirm that every batch meets the same standards used in clinical research.
  • Infinity Pharma BrazilcoreChannel Partner/ Reseller/ Distributor · 30 July 2024NXT-USA announced partnership with Infinity Pharma Brazil to launch Digexin in Brazil under the brand name Motility. This partnership expands global footprint and brings digestive wellness products to the Brazilian market.
  • Shanghai Nutra (Shanghai Freemen)coreChannel Partner/ Reseller/ Distributor · 4 October 2022NXT-USA partnered with Shanghai Nutra to launch Digexin as a new digestive health ingredient at SupplySide West in October 2022. Shanghai Nutra serves as a distribution and co-marketing partner for the Chinese and Asian markets.
  • Laila Nutra Private LimitedcoreStrategic or Co-development PartnerXeya trademark is owned by Laila Nutra Private Limited. NXT-USA has an exclusive or licensed relationship for the Xeya Modern Shatavari ingredient in global markets. Laila Nutra developed the proprietary extraction and standardization process delivering 15% shatavarins.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

NXT-USA competitors and assessment

Company assessment

Direct peers

  • Sabinsa: Specializes in branded, patented, clinically validated botanical ingredients (e.g., curcumin C3 Complex, Boswellin) sold B2B to supplement manufacturers worldwide — directly comparable model to NXT-USA across turmeric/joint and women's health adjacencies.
  • OmniActive Health Technologies: Supplies branded, science-backed nutraceutical ingredients (e.g., Lutemax, BioCurc) to brands globally — same B2B ingredient-supplier model, patent/trademark protected SKUs, and emphasis on peer-reviewed clinical evidence.
  • Gencor: Global supplier of branded botanical extracts and ingredients (e.g., Libifem, Tesnor) targeting women's health, men's health, and general wellness — directly comparable ingredient portfolio and B2B go-to-market.
  • PLT Health Solutions: B2B ingredient supplier focused on branded, clinically supported botanicals and naturals sold into supplement and functional food brands — comparable branded-ingredient distribution model.
  • Nexira: Global supplier of natural botanical and nutritional ingredients with strong digestive-health and joint-health categories — directly comparable B2B ingredient model with overlap on gut-health adjacencies to Digexin.
  • DolCas Biotech: Supplies branded, clinically researched botanical extracts (e.g., Curcugen, BosPure) to supplement manufacturers — same patented/standardized botanical B2B model with overlap on joint and inflammation categories.
  • Verdure Sciences: Supplies branded, patented botanical extracts (e.g., Pomella, LongVida) to dietary supplement brands — comparable B2B ingredient model with emphasis on clinical substantiation and trademarked SKUs.
  • Ingredients by Nature: Supplier of branded, research-backed botanical extracts (e.g., Curcumin C3, Prime Naturally) to supplement manufacturers — comparable B2B go-to-market and clinically validated positioning.
  • Kuber Impex: India-based supplier of botanical and nutraceutical raw materials and proprietary extracts, including turmeric/curcumin derivatives — comparable upstream sourcing and B2B ingredient supplier model.
  • Natural Remedies: India-headquartered manufacturer of clinically validated branded botanical extracts (e.g., BacoMind, Boswellia) supplied B2B to global supplement brands — directly comparable model on clinical validation, IP, and joint/women's health categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

NXT-USA social profiles

Digital presence

NXT-USA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NXT-USA leadership team

Management profile

Number of profiles

Profiles2 records

NXT-USA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NXT-USA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NXT-USA

What does NXT-USA do?

NXT-USA supplies four proprietary, clinically validated botanical branded ingredients — TamaFlex (joint health), Xeya Modern Shatavari (women's hormonal health), Digexin (digestive health and gut-brain axis), and BluNADBooster (NAD+ longevity) — to nutritional supplement manufacturers and finished product brands globally. Revenue is generated by selling these patented or patent-pending ingredient formulations, backed by human clinical studies, under licensing and direct supply agreements.

Is NXT-USA a public or private company?

NXT-USA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NXT-USA founded?

NXT-USA was founded in -1. It employs 11 to 50 people.

Where is NXT-USA based?

NXT-USA is headquartered in Edison, United States, in the North America region.

How does NXT-USA make money?

Two revenue lines are on record. B2B Ingredient Sales are the primary driver. The others are B2B Sales Model.

Who are NXT-USA's main competitors?

Direct peers on record are Sabinsa, OmniActive Health Technologies, Gencor, PLT Health Solutions, Nexira, DolCas Biotech, Verdure Sciences, Ingredients by Nature, Kuber Impex and Natural Remedies.

Does NXT-USA have an API?

No public API is recorded for NXT-USA.

What industry is NXT-USA in?

NXT-USA's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Drug Store NewsIs digestive health still a probiotics category?The digestive health supplement market is evolving beyond probiotics as consumers increasingly seek specific symptom relief rather than general microbiome modulation. Companies such as Boiron, Culturelle, Nordic Naturals, and NXT USA are launching diverse products targeting issues like bloating, motility, and constipation with varying scientific backing. This shift challenges the traditional dominance of probiotic ingredients in the category.Nutraceutical Business ReviewNXT USA debuts gut health ingredient Motility in BrazilNXT USA has launched its gut health ingredient, now branded as Motility in Brazil, in partnership with Infinity Pharma Brazil. The product launch took place at the Consulfarma Congress in Sao Paulo to address digestive health and stress management through a plant-based formula.Nutraceutical Business ReviewNutraceutical Business ReviewThe article serves as an industry overview of the nutraceutical sector, highlighting product launches and clinical validations occurring at major trade shows like Vitafoods Europe 2026. It details specific innovations from companies such as NXT USA, Twin Arbor Labs, and OmniActive, focusing on ingredients targeting metabolic health, skin resilience, and cognitive performance. The report also notes broader market trends, including the impact of GLP-1 medications on consumer demand for high-protein foods and personalized nutrition.